Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
President Joe Biden’s proposal to have GLP-1 weight-loss drugs such as Ozempic and Mounjaro covered by Medicare and Medicaid would help tackle the public-health crisis of obesity, but it would raise the costs for the government programs by billions of dollars per year.
Thanksgiving may feel different for Americans on weight loss drugs. Here's why.
This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.
GLP-1 weight-loss drugs might help protect kidneys
In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs in people with or without diabetes. GLP-1s include blockbuster diabetes medicines such as Ozempic and its weight-loss spinoff, Wegovy.
Wegovy costs $1,349 in the US vs. $92 in the UK. Why are weight loss drugs so pricey?
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce risks with obesity.
These Are the Thanksgiving Foods You Should Skip if You’re on Ozempic or Other Weight Loss Drugs
“I love Thanksgiving for the pumpkin pie — it's such a low-sugar dessert that it tends to be fine for your blood sugar,” Bensley tells PEOPLE. “Chocolate is okay, but just try to do it with your meal to keep that blood sugar stable.”
How to Navigate the Holidays on a Weight-Loss Drug
For the 12% of adults in the U.S. now taking a weight-loss medication that targets the GLP-1 and/or GIP hormones to restrict appetite or treat diabetes—think Ozempic, Wegovy, Mounjaro, and Zepbound—the season is even more complicated.
Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Biden Proposes Medicare and Medicaid Cover Costly Weight-Loss Drugs for Millions of Obese Americans
Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morni
Weight loss drugmakers in spotlight as White House proposes coverage
The Biden-Harris Administration has proposed a new rule to expand coverage of anti-obesity medications for Americans with Medicare and
Biden proposes expanded coverage for weight loss drugs under Medicare, Medicaid
The Biden administration has proposed a plan for Medicare and Medicaid to offer coverage for weight loss medications, such as Ozempic and Wegovy.
Biden Proposes Expanded Medicare, Medicaid Coverage of Obesity Drugs
Current rules for the Medicare and Medicaid government health insurance programs cover the use of drugs such as Mounjaro, Ozempic and Wegovy for certain conditions like diabetes, but not for obesity as a condition on its own.
5 GLP-1 marketing trends as brands jump on weight loss drug craze
As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.
More Ozempic Users Doubt They Can Keep Weight Off Without Drug: Study
Only two in five people taking GLP-1 medication were confident they would maintain their weight loss after stopping the ...
West Virginia residents struggle to afford GLP-1 weight loss drugs after state ends subsidy program
In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...
Forbes3h
Employers May Follow Medicare Coverage Of GLP-1 Weight Loss Drugs
Currently, fewer than one in five large employers are covering such prescriptions despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, according to a KFF analysis ...
Losing Weight With Ozempic Might Also Lighten Your Bar Tab, Study Finds
A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...